Advancing Water and Dialysate Standards for High-Volume Hemodiafiltration in the United States: From Scientific Rationale to Clinical Implementation.

High-volume post-dilution hemodiafiltration (HVHDF), defined by a convection volume ≥23 L/session, is associated with improved survival and clinical outcomes compared with conventional high-flux hemodialysis. Because HVHDF requires infusion of large volumes of sterile substitution fluid, treatment safety depends on rigorous control of dialysis water and fluid purity. With expanding interest in the United States, guidance on quality standards and implementation is needed. We conducted a narrative review of current evidence and technical standards governing dialysis water, dialysate, and online-produced substitution fluid. International quality frameworks, including the ISO 23500 series and ANSI/AAMI standards, were examined alongside principles of system validation, microbiological surveillance, and risk management relevant to U.S. clinical practice. Emerging technologies for rapid microbial detection and resource optimization were also evaluated. HVHDF consistently achieves greater small- and middle-molecule clearance, reduced inflammatory markers, improved hemodynamic stability, and favorable clinical outcomes, with benefit closely related to delivered convective dose. Safe implementation requires validated multistage water treatment systems capable of consistently meeting ANSI/AAMI RD52 chemical and microbial standards, while dialysis machines ensure production of ultrapure dialysate and sterile, nonpyrogenic substitution fluid through integrated ultrafiltration safeguards. Structured surveillance programs, bacteria- and endotoxin-retentive filtration, and adherence to defined chemical and microbiological thresholds are essential. Although international standards have largely converged, certain U.S. regulatory references continue to reflect earlier AAMI documents. Technological innovations, including high-efficiency reverse osmosis, automated dialysate flow adjustment, and controlled ultrafiltration, enable delivery of high convective volumes while containing water and energy use. Dialysis water and fluid purity are foundational to safe, scalable HVHDF. In the evolving U.S. landscape, integration of validated water systems, structured surveillance, and technology-supported prescription optimization is essential to realize the clinical and sustainability potential of online HDF.